Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Visceral Pain Treatment Market

Published Date : Jul 2023

Visceral pain results from the activation of nociceptors in the viscera (organs) of the pelvis, chest, or abdomen. Visceral structures are very sensitive to stretching (stretching), inflammation, and ischemia, but moderately sensitive to other stimuli that often cause... View more

Coherent Market Insights Asia Gout Disease Treatment Market

Published Date : Jul 2023

Gout is a chronic disease characterized by pain and inflammation in the joints. It is also known as gout arthritis, in which a high level of uric acid in the blood leads to the formation of needle-like crystals in the joints, resulting in inflammation and pain. This c... View more

Coherent Market Insights Toxoplasmosis Treatment Drugs Market

Published Date : Jul 2023

Toxoplasmosis is an infection caused by a parasite called Toxoplasma gondii. Currently recommended toxoplasmosis drugs target the tachyzoite stage of the parasite and do not remove the parasite from the tissues. Pyrimethamine is considered the most effective anti-toxo... View more

Coherent Market Insights India Intravenous Anesthetic Market

Published Date : Jul 2023

Intravenous anesthetics are medications that are administered through a vein to induce and maintain anesthesia during surgical procedures. They work by depressing the central nervous system and causing loss of consciousness, loss of sensation, and muscle relaxation. S... View more

Coherent Market Insights Neuropathic Pain Market

Published Date : Jul 2023

Neuropathic pain is a condition which involves pain caused due to damage or diseases affecting the nervous system. These conditions may include diseases such as diabetes causing diabetic neuropathy, chemotherapy induced neuropathic pain, and trigeminal neuralgia. Diab... View more

Coherent Market Insights Tauopathies Treatment Market

Published Date : Jul 2023

Tauopathies are a diverse category of neurodegenerative disorders distinguished by abnormal tau protein metabolism (tau prions) that ultimately leads to a significant loss of brain cells. The "microtubules" of the cell are stabilized by tau proteins. Misfolding causes... View more

Coherent Market Insights Menstrual Cup Market

Published Date : Jul 2023

Menstrual cups are an eco-friendly alternative to tampons and pads. It is a sanitary product that is inserted into the vagina and made from medical-grade material that is safe for intimate use. It is used to prevent leakage during the menstrual cycle, and can be worn ... View more

Coherent Market Insights Antihyperlipidemic Drugs Market

Published Date : Jul 2023

Hyperlipidemia is a term that encompasses various genetic and acquired disorders that describe an elevated lipid levels, such as cholesterol and triglycerides, in the blood, which in turn increases the risk of heart disease and stroke, the leading cause of death world... View more

Coherent Market Insights Radiodermatitis Market

Published Date : Jul 2023

Radiodermatitis (radiation dermatitis, radiation-related skin reactions, or radiation damage) is a serious side effect of ionizing radiation  during cancer therapy and nuclear attacks and disasters such as  Fukushima in 2011. Specifically, 95% of cancer pati... View more

Coherent Market Insights Asia Pacific Facial Care Market

Published Date : Jul 2023

Skincare is an essential regime followed for maintaining the health condition of the skin. A good skincare routine will allow you to maintain a healthy and bright appearance. It ensures face looks clear and fresh regardless of the pollutants and other damages that mig... View more

Coherent Market Insights Europe Heparin Market

Published Date : Jul 2023

Heparin is obtained naturally from the mucous membranes of slaughtered meat animals, such as pig intestines or cow lungs, or it is produced synthetically. It is also known as unfractionated heparin (UFH) and is used as an anticoagulant in the treatment of acute corona... View more

Coherent Market Insights Inhaled Antibiotics Market

Published Date : Jul 2023

Inhaled drugs are an important part of treatment for chronic lung disease, as the medicine rapidly reaches the airways. Metered-dose inhalers (MDIs), dry powder inhalers, nebulizers, and soft mist inhalers are currently available with different medicines for the treat... View more

Coherent Market Insights Glaucoma Eye Drops Market

Published Date : Jul 2023

Glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. The symptoms can start so slowly that a patient may not notice them. The only way to find out if a person has glaucoma is t... View more

Coherent Market Insights Mea Technetium 99m Market

Published Date : Jul 2023

Technetium -99m is an isomer of technetium 99, which is used in nuclear medicine and the precursor for technetium-99 is molybdenum-99, a radioactive nuclei generally produced in reactors. Technetium-99m is used as a radioactive tracer and can be detected in the body b... View more

Coherent Market Insights Asia Pacific Alopecia Treatment Market

Published Date : Jul 2023

Alopecia areata is a common autoimmune disease that causes unpredictable hair loss. Alopecia areata is a common autoimmune disease that causes hair loss or sometimes it can lead to baldness. Scarring alopecia is a condition characterized by hair loss and scarring. Hai... View more

Coherent Market Insights Healthcare Contract Research Outsourcing Market

Published Date : Jul 2023

Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current sce... View more

Coherent Market Insights Regenerative Therapies Market

Published Date : Jun 2023

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerat... View more

Coherent Market Insights Androgen Replacement Therapy Market

Published Date : Jun 2023

Androgen substitution treatment (ART), frequently refered to as testosterone substitution treatment (TRT), is a type of chemical treatment, wherein androgens, frequently testosterone, are supplanted. In order to combat the effects of male hypogonadism, ART is frequent... View more

Coherent Market Insights Human Immunoglobulin Ph4 For Intravenous Injection Market

Published Date : Jun 2023

Human immunoglobulin for intravenous injection (IVIG) has the capacity of proving passive immunity and anti-inflammatory, immunomodulatory effect which results in better treatment and prognosis of severe infections such as COVID-19. The IgG antibodies extracted from r... View more

Coherent Market Insights Antiparasitic Drugs Market

Published Date : Jun 2023

Antiparasitic drugs are utilized to address various types of infections caused by a wide array of parasites. Parasites are small organisms that reside on or inside humans and animals. There are numerous antiparasitic drugs available, each designed to target a specific... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.